Risk of Negative Clinical Outcomes When Using Acid-reducing Agents with Protease Inhibitor-based HAART

Posted by Administrator on February 24th, 2006 — in Nexium Top News

The introduction of protease inhibitor-based HAART a decade ago has revolutionized the treatment and management of HIV infection and AIDS. Now researchers have created new PIs, and with the addition of ritonavir (Norvir), produced boosted PI regimens that are bringing additional advantages to the use of this unique antiretroviral drug class: greater drug tolerability, improved […]

Generics Give Originators Heartburn

Posted by Administrator on February 24th, 2006 — in Nexium Top News

Like most people, I occasionally binge on spicy food and pay the price with heartburn. A simple antacid usually fixes the problem for me — but for some people, heartburn is a perpetual problem. Generic competition for the drugs to treat this malady may be sweet relief for those unlucky folks, but it’s more aggravation […]

AstraZeneca Commences Patent Infringement Litigation Against Ranbaxy Laboratories

Posted by Administrator on February 24th, 2006 — in Nexium Top News

AstraZeneca announced today that it has filed a lawsuit in the United States District Court for the District of New Jersey against Ranbaxy Laboratories for willful infringement of AstraZeneca’s patents protecting NEXIUM® (esomeprazole magnesium).
The lawsuit is in response to an Abbreviated New Drug Application filed by Ranbaxy with the US Food and Drug Administration […]

AstraZeneca sued over Nexium

Posted by Administrator on February 24th, 2006 — in Nexium Top News

Glenn Crenshaw was taken aback in 2001 when the pharmacist told him his co-pay for a month’s supply of Prilosec had risen to $35 from $15. That extra $20 a month was a stretch, Crenshaw says, because back and knee injuries left him unable to work.
At his next doctor’s appointment, Crenshaw asked whether he could […]

Esomeprazole Reduces Upper GI Symptoms Associated With NSAID Use

Posted by Administrator on February 24th, 2006 — in Nexium Top News

WILMINGTON, DE, May 12, 2005 – Results from two clinical trials, published in the American Journal of Gastroenterology, demonstrate that Nexium (esomeprazole magnesium) can reduce upper gastrointestinal (GI) symptoms – such as moderate to severe pain, burning and discomfort in the upper abdomen– associated with continuous, daily use of non-steroidal anti-inflammatory drugs (NSAIDs), including selective […]